Prodways Group SA — Cyborg Score 4/10

Challenged
Industrial Additive Manufacturing / 3D Printing

Strategic Profile

Prodways positions itself as a vertical integration player in additive manufacturing with strong geographic presence in France (59.7% of sales) and Europe (32.6%). However, the company faces operational headwinds with negative earnings (EPS -0.31) and elevated leverage, trading at distressed valuations that reflect execution risks despite exposure to growing aerospace and healthcare end-markets.

Cyborg Score Rationale

EPS remains negative at -0.31, and the company carries operational risks. Key risks include negative net income margins, net debt to EBITDA around 2.54, and exposure to cyclical end-markets like aerospace and dental. The company trades at low multiples reflecting financial distress despite being in a structurally growing 3D printing sector.

Top Insights

  • Market cap €43.53M with stock trading at €0.84, indicating deep liquidity constraints for a technology/manufacturing player
  • Price-to-book is 0.80 and price-to-sales is 0.78, indicating cheap valuation versus Technology sector averages, reflecting market distrust
  • Catalysts that can trigger a sustained move include stronger order flow in healthcare or industrial segments and margin improvement from product mix
  • Company exhibits oversold technical patterns with recovery above 50-day moving averages, but fundamental recovery requires contract wins and operational profitability

Named Competitors

  • SLS and Polymer Additive Manufacturing — Diversified 3D printing systems and materials provider with global scale
  • Selective Laser Sintering — German industrial 3D printing systems provider for metal and polymer printing
  • Stereolithography Systems — Industrial additive manufacturing for production-grade parts

Recent Developments

  • (Feb 2026) Stock bounced from €0.41 year-low to €0.84 with elevated trading volume signaling institutional interest in oversold conditions
  • (Feb 2026) Technical indicators show recovery above 50-day (€0.69) and 200-day (€0.60) moving averages despite negative earnings
  • (2025) Company continues exposure to aerospace, dental, and medical 3D printing segments despite financial headwinds

Open the full interactive Prodways Group SA report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →